Trials to watch: First cancer vaccine success could trigger a domino effect
Following the first successful Phase III trial of an mRNA cancer vaccine, interest in the modality has surged.
Following the first successful Phase III trial of an mRNA cancer vaccine, interest in the modality has surged.